MedTrace Logo

Transgender In Transition

NCT04028219 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 750

Last updated 2022-11-08

No results posted yet for this study

Summary

Prospective trial in gender dysphoric patients who undergo gender-affirming hormone therapy, aiming to investigate psychological, biological and behavioural consequences of hormonal therapy.

Conditions

Interventions

DIAGNOSTIC_TEST

Online surveys

Psychometric measures within 14 online surveys, which is one at each assessment point (before and 3, 6, 9, 12, 24, 36, 48, 60, 72, 84, 96, 108, 120 months after hormonal therapy).

Sponsors & Collaborators

  • Universitätsklinikum Hamburg-Eppendorf

    lead OTHER

Principal Investigators

  • Johannes Fuß, MD · Institute for Sex Research, Sexual Medicine and Forensic Psychiatry

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-05-15
Primary Completion
2024-05-15
Completion
2034-05-15

Countries

  • Germany
  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04028219 on ClinicalTrials.gov